Vanguard Group’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,712,294
Closed -$37.6M 4239
2015
Q1
$37.6M Buy
4,712,294
+95,291
+2% +$668K ﹤0.01% 2043
2014
Q4
$26.2M Sell
4,617,003
-158,350
-3% -$853K ﹤0.01% 2142
2014
Q3
$23.6M Buy
4,775,353
+32,368
+0.7% +$175K ﹤0.01% 2136
2014
Q2
$27M Sell
4,742,985
-26,283
-0.6% -$156K ﹤0.01% 2100
2014
Q1
$35.2M Buy
4,769,268
+133,607
+3% +$982K ﹤0.01% 1985
2013
Q4
$33.2M Sell
4,635,661
-87,140
-2% -$647K ﹤0.01% 1975
2013
Q3
$36.6M Buy
4,722,801
+134,635
+3% +$1.05M ﹤0.01% 1893
2013
Q2
$29.9M Buy
+4,588,166
New +$28.9M ﹤0.01% 1913

Vanguard Group's ELX Position: Q2 2015 in Review

Vanguard Group sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 4,712,294 shares — an estimated $37.6M sold.

Vanguard Group first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $37.6M in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Vanguard Group reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Vanguard Group sold 4,712,294 EMULEX CORP shares in Q2 2015, an estimated $37.6M.
  • Vanguard Group first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Vanguard Group's EMULEX CORP position peaked at $37.6M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.